Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03286114
Title Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Michigan Cancer Center

myelodysplastic syndrome

acute lymphoblastic leukemia

acute myeloid leukemia



Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.